Research Article
Gastric Mucinous Cancer Histology: Clinicopathological Characteristics and Prognostic Value
Table 3
Survival comparisons between MC and WMDC patients for gastric cancer.
| | | WMDC | MC |
value | value |
| | Total | | | 12.61 | 0.004 | | 1-year OS rate | 83.4% | 64.3% | | | | 3-year OS rate | 60.5% | 37.1% | | | | 5-year OS rate | 50.9% | 29.4% | | | | Early stage | | | 0.676 | 0.411 | | 1-year OS rate | 100.0% | 100.0% | | | | 3-year OS rate | 95.5% | 100.0% | | | | 5-year OS rate | 92.5% | 100.0% | | | | Advanced stage | | | 5.741 | 0.017 | | 1-year OS rate | 79.8% | 63.2% | | | | 3-year OS rate | 52.3% | 34.8% | | | | 5-year OS rate | 41.6% | 26.5% | | |
|
|
OS: overall survival.
|
